Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Pain Medicine (Malden, Mass.)|March 31, 2026
The Safety and Effectiveness of Lumbar Transforaminal Injection of Sterile Amniotic Fluid Filtrate Compared to Steroid for Lumbosacral Radicular Pain Due to Spinal Stenosis: A Phase I/II Double-Blinded Randomized TrialZachary L McCormick, Hasan Sen, Amanda N Cooper, et al.
Pain Medicine (Malden, Mass.)|September 2, 2025
The Effectiveness of Basivertebral Nerve Radiofrequency Ablation for the Treatment of Vertebrogenic Low Back Pain: 1-Year Results of a Prospective Real-World Cohort StudyZachary L McCormick, Alexandra E Fogarty, Aaron Conger, et al.
Molecular Cancer Therapeutics|January 9, 2015
The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic AgentsJude Canon, Tao Osgood, Steven H Olson, et al.
Molecular Cancer Therapeutics|July 29, 2010
Selective and potent Raf inhibitors paradoxically stimulate normal cell proliferation and tumor growthJosette Carnahan, Pedro J Beltran, Carol Babij, et al.
Cancer Research|February 3, 2006
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumorsTeresa Burgess, Angela Coxon, Susanne Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
N-Aryl-gamma-lactams as integrin alphavbeta3 antagonistsNing Xi, Stephen Arvedson, Shawn Eisenberg, et al.
Cancer Research|September 5, 2006
AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenograftsAnthony Polverino, Angela Coxon, Charlie Starnes, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Discovery of N-phenyl nicotinamides as potent inhibitors of KdrCelia Dominguez, Leon Smith, Qi Huang, et al.
Molecular Cancer Therapeutics|May 20, 2016
In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer ModelsPaul E Hughes, Karen Rex, Sean Caenepeel, et al.
Journal of Medicinal Chemistry|January 15, 2015
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK)Adrian L Smith, Kristin L Andrews, Holger Beckmann, et al.
Pageof 7